A groundbreaking "personalised" online device designed to identify optimum medication for type 2 diabetes patients could be a game-changer for millions, experts have suggested. Researchers at the ...
The findings suggest that intranasally delivered FGF-1 may reverse type 2 diabetes by targeting dysfunctional glucose-sensing ...
Argentine scientists have identified a mechanism that allows pancreatic beta cells, which produce insulin, to become ...
PLEASANTON, Calif., Nov. 4, 2025 /PRNewswire/ -- Aqua Medical, a company advancing Endoscopic Metabolic Restoration for type 2 diabetes, today announced that the U.S. Food and Drug Administration (FDA ...
A groundbreaking development in diabetes treatment reveals that SGLT-2 inhibitors significantly reduce dementia risk among type 2 diabetes patients. Recent research demonstrates these medications ...
The MarketWatch News Department was not involved in the creation of this content. PLEASANTON, Calif., Nov. 4, 2025 /PRNewswire/ -- Aqua Medical, a company advancing Endoscopic Metabolic Restoration ...